IL13RA1 and infection: The levels of these molecules with corilagin treatment of different concentrations were decreased compared with the model infection group (p < 0.01 or p < 0.05, Student's t-test, n = 6), and the inhibitory effects increased with increasing concentrations of corilagin (p < 0.05, one-way ANOVA, post-hoc: S-N-K method, n = 6), which confirmed the dose-dependent inhibitory effect of corilagin on IL-13Rα1 signaling pathway in vivo.